Vanda Pharmaceuticals (VNDA) Misses Q4 EPS by 1c

February 12, 2013 7:31 AM EST Send to a Friend
Vanda Pharmaceuticals, Inc. (NASDAQ: VNDA) reported Q4 EPS of ($0.23), $0.01 worse than the analyst estimate of ($0.22). Revenue for the quarter came in at $7.9 million versus the consensus estimate of $8.6 million.

For earnings history and earnings-related data on Vanda Pharmaceuticals, Inc. (VNDA) click here.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings

Related Entities

Earnings

Add Your Comment